Notable Facts
→EVP & Chief Commercial Officer at Ultragenyx Pharmaceutical Inc (NASDAQ: RARE)
→Naval veteran - served as Lieutenant Commander in Naval Aviation and Congressional Fellow
→MBA from Wharton School and BS from US Naval Academy
→Over 20 years of commercial expertise in biopharmaceutical industry
→Led successful launches of multiple rare disease therapies including Crysvita, Mepsevii, and Dojolvi
→Previously VP of Commercial at Crescendo Bioscience (Myriad Genetics subsidiary)
→Serves on boards of directors at Inozyme Pharma and Rezolute
→Has 500+ LinkedIn connections
→Previous experience at Intermune, Elan Pharmaceuticals, Genentech, and Bristol-Myers Squibb
→Member of the executive leadership team at Ultragenyx